Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : T/FIF, a New Plateau -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (283)	10/25/2000 8:50:14 AM
From: scaram(o)uche	Read Replies (1) \| Respond to of 2243

Early returns on "trickle down" will be in tomorrow at the close. Given after hours trading, I don't know what time "close" represents...... Molecular Devices Corporation Third Quarter Earnings Release And Conference Call Molecular Devices Corporation (Nasdaq: MDCC), will announce financial results for the third quarter after the close of market on October 26, 2000. Management of the company will hold a conference call to discuss the company's third quarter 2000 results on Friday, October 27, 2000 at 11:00 a.m. (EDT). Details of the conference call are as follows: When: Friday, October 27, 2000 at 11:00 a.m. (EDT) 8:00 a.m. (PDT) Live Conference Call: Dial in: 973-633-6740 A taped replay of this call will be available through 11/3/00. The dial in numbers for the replay are: 402-220-0468 and 877-790-5752. Live Web Cast: Go to Investor page at moldev.com. A replay of this web cast will remain at this location through 11/3/00. Contact Info: Tim Harkness, CFO/VP Finance, 408-747-3533, or ir@moldev.com Molecular Devices Corporation is a leading developer of high-performance, bioanalytical measurement systems that accelerate and improve drug discovery and other life sciences research. The Company's systems enable pharmaceutical and biotechnology companies to leverage advances in genomics and combinatorial chemistry by facilitating the high throughput and cost effective identification and evaluation of drug candidates. The Company's instrument systems are based on its advanced core technologies which integrate its expertise in engineering, molecular and cell biology and chemistry and are fundamental tools for drug discovery and life sciences research. SOURCE Molecular Devices Corporation Web Site: moldev.com